series-b
Stage
1
Investors
About
enGene Therapeutics is a clinical-stage biotechnology company developing a novel gene therapy platform for the local delivery of therapeutics. Its lead product candidate, EG-70, is being evaluated in a pivotal study for non-muscle invasive bladder cancer.
Explore enGene Therapeutics Inc.'s full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.